Related Experiment Video

Updated: Jan 29, 2026

The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
05:48

The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients

Published on: June 12, 2020

6.3K

[Treatment of attention-deficit/hyperactivity disorder in clinical practice. A retrospective study]

Ana López-López1, María Luisa Poch-Olivé2, Javier López-Pisón3

  • 1Departamento de Psicología, Hospital Son Llatzer, Son Ferriol, Islas Baleares, España.

Medicina
|February 19, 2019
PubMed

Insights

Methylphenidate, particularly immediate-release formulations, is the primary pharmacological treatment for Attention Deficit Hyperactivity Disorder (ADHD) in children. Early treatment onset significantly impacts therapeutic outcomes.

Area of Science:

  • Neuroscience
  • Pediatric Psychiatry
  • Pharmacology

Background:

  • Attention Deficit Hyperactivity Disorder (ADHD) is a prevalent, chronic neurodevelopmental disorder with complex genetic and environmental influences.
  • ADHD often presents with comorbid conditions, affecting a significant majority of diagnosed children.
  • Understanding therapeutic management patterns is crucial for optimizing ADHD care.

Purpose of the Study:

  • To retrospectively analyze the therapeutic management strategies employed in children diagnosed with ADHD.
  • To identify the most common pharmacological treatments and factors influencing treatment choices.
  • To investigate the relationship between treatment type, patient demographics, and treatment outcomes.

Main Methods:

  • Retrospective analytical study design.
  • Inclusion of a sample of 82 children diagnosed with ADHD.
  • Analysis of treatment modalities, including pharmacological interventions (methylphenidate, atomoxetine) and their formulations.

Main Results:

  • Pharmacological treatment was the predominant therapeutic approach (90.2%).
  • Methylphenidate, in both immediate-release (46.0%) and sustained-release (51.4%) formulations, was the most frequently prescribed medication.
  • Atomoxetine use was minimal (2.7%), and treatment abandonment occurred in 20.3% of patients. A significant correlation was observed between the age of treatment onset and outcomes, unlike gender or ADHD subtype.

Conclusions:

  • Pharmacological treatment, especially methylphenidate, remains the cornerstone of ADHD management in this pediatric cohort.
  • The low utilization of non-stimulant alternatives like atomoxetine warrants further investigation.
  • Early initiation of ADHD treatment is a critical factor influencing therapeutic success.

Keywords:
atomoxetineattention deficit hyperactivity disordermethylphenidatepsychoeducationpsychological treatment

More Related Videos

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD10:02

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD

Published on: March 12, 2020

16.6K
A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients03:47

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients

Published on: October 25, 2024

641

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
896
Treatment Strategies for Psychological Disorders01:24

Treatment Strategies for Psychological Disorders

Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
764
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
333
Intrinsically Disordered Proteins02:18

Intrinsically Disordered Proteins

Intrinsically disordered proteins are a group of proteins that do not fold into specific three-dimensional structures. Their structural flexibility allows them to complement ordered proteins to perform functions that are inaccessible to rigid structures. They are more common in eukaryotes than prokaryotes and may either be exclusively intrinsically disordered or hybrid proteins, consisting of a mix of ordered and disordered regions. The absence of a rigid structure in these proteins can be...
19.4K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
535
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
335